Insulin increases glucose transport into target tissues by promoting the exocytosis of the glucose transporter GLUT4 from intracellular vesicles to the plasma membrane (1, 2). In recent years, it has emerged that there are two pathways required for insulin-stimulated glucose transport, namely an insulin receptor substrate/PI 1 3-kinase pathway and a PI 3-kinase independent pathway involving the c-Cbl-associated protein (CAP) and the tyrosine phosphorylation of c-Cbl (2). Although c-Cbl was thought to be recruited by CAP, it has also emerged that APS (adapter protein with a PH and SH2 domain), a member of a larger adapter protein family, can also recruit c-Cbl following insulin-stimulation (3, 4). Following the binding of insulin, the insulin receptor undergoes autophosphorylation in the activation loop of the kinase domain. This provides docking sites for the binding of several proteins, including SH2-B and the APS adapter protein (5-8).
Insulin increases glucose transport into target tissues by promoting the exocytosis of the glucose transporter GLUT4 from intracellular vesicles to the plasma membrane (1, 2) . In recent years, it has emerged that there are two pathways required for insulin-stimulated glucose transport, namely an insulin receptor substrate/PI 1 3-kinase pathway and a PI 3-kinase independent pathway involving the c-Cbl-associated protein (CAP) and the tyrosine phosphorylation of c-Cbl (2) . Although c-Cbl was thought to be recruited by CAP, it has also emerged that APS (adapter protein with a PH and SH2 domain), a member of a larger adapter protein family, can also recruit c-Cbl following insulin-stimulation (3, 4) . Following the binding of insulin, the insulin receptor undergoes autophosphorylation in the activation loop of the kinase domain. This provides docking sites for the binding of several proteins, including SH2-B and the APS adapter protein (5) (6) (7) (8) .
The resulting recruitment of the APS adapter protein to the kinase domain allows it to undergo tyrosine phosphorylation on Tyr-618 (7) . The phosphorylated Tyr-618 then allows APS to bind to the variant SH2 domain of c-Cbl (8) . This is followed by the tyrosine phosphorylation of c-Cbl on tyrosines 700 and 774, resulting in phosphorylated c-Cbl binding to the SH2 domain of Crk (4, 9) . It is also thought that the adapter protein CAP could facilitate interaction with the insulin receptor, because CAP was also identified as a c-Cbl binding protein using c-Cbl as a bait in a yeast two-hybrid screen and was shown to interact with the insulin receptor in intact cells (10) . CAP contains an N-terminal region homologous to Sorbin (Sorbin homology/ SOHO domain) and three SH3 domains in the C terminus (10) . CAP is constitutively bound to a proline-rich region in Cbl through its C-terminal SH3 domain (11) . Recently, a number of new splice variants of CAP have been described (12) . Following the insulin-stimulated phosphorylation of c-Cbl, the CAP/Cbl complex migrates to the caveolin-rich lipid rafts, a movement facilitated by the interaction of the CAP SOHO domain with flotillin, a protein in lipid rafts (13) . This allows the Crk/C3G complex to be recruited to this microdomain, where C3G activates the small G protein TC10 (14) . The activation of TC10 occurs independently of PI 3-kinase and is crucial for insulinstimulated Glut4 translocation (2) .
Since APS and CAP both interact with c-Cbl (3, 4, 8, 10) , the relative individual importance and the temporal sequence of these proteins in recruiting c-Cbl has not been clear. In this study, we sought to determine whether both proteins were required to recruit c-Cbl to the insulin receptor or whether they were mutually exclusive. We addressed this question by coexpression of APS and CAP in cells that do not express these proteins and by silencing of the mouse APS gene. Here we provide evidence that APS is the key protein recruiting both CAP and c-Cbl to the receptor and that insulin regulates the association of CAP with APS by promoting its dissociation. Furthermore, we also find that SH2-B␣ interacts constitutively with CAP and dissociates following insulin stimulation.
EXPERIMENTAL PROCEDURES
Materials-Anti-FLAG M2-horseradish peroxidase antibody and anti-Myc antibodies were purchased from Sigma. Anti-CAP, anti-GLUT4, anti-actin, anti-insulin receptor, and anti-Cbl antibodies specific for c-Cbl (C-15) and Cbl-b (C-20) were purchased from Santa Cruz Biotechnology. Anti-PhosphoCbl 774 was purchased from Cell Signaling Technology/NEB. siRNA duplexes (Smartpool) targeting human c-Cbl and Cbl-b were purchased from Dharmacon Inc. (Lafayette, CO). 2-deoxy-
3 H]glucose was purchased from Amersham Biosciences. All other reagents and CHO.T cells and CHO.T APS cells were as described previously (3) . FLAG-tagged mouse CAP1 cDNA was kindly provided by Dr. Alan Saltiel (University of Michigan) and subcloned into pIRES puro (Clontech). CHO.T cells, CHO.T-APS, and CHO.T-SH2-B cells were transfected with FLAG-CAP using FuGENE 6. 48 h later, puromycin was added to the medium, and the cells were left for 10 days. Surviving clones were isolated by limiting dilution, and expression of CAP was confirmed by Western blotting using anti-FLAG antibodies. Deletions of the rat APS were generated by restriction enzyme digestion. All constructs were verified by automated sequencing.
Subcellular Fractionation-Serum-starved cells were stimulated with insulin as indicated in the legends to Figs. 3 and 5-7, and the cells were lysed as described previously (15) . The lysis buffer was added, and the cells were scraped and placed on ice for 10 min. The lysate was then clarified by centrifugation for 10 min at 10,000 ϫ g at 4°C. The supernatant was then used for whole cell lysates and immunoprecipitation.
The remaining pellet was resuspended in 100 l of radioimmune precipitation assay buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS), vortexed, placed on ice, and sonicated for 15 s. The sonicated lysate was then cleared by centrifugation at 10,000 ϫ g for 10 min at 4°C. The supernatants were mixed with 70 l of 2ϫ Laemmli buffer and heated for 5 min at 100°C. This detergent-insoluble fraction is referred to as the pellet in the Fig.  6 legend.
Indirect Immunofluorescence and Confocal Microscopy-The protocol for immunofluorescent staining was as described (16) . Cells were cultured on 19-mm coverslips for 48 h and, at semiconfluence, they were serum-starved or stimulated with insulin. The cells were then washed twice with ice-cold PBS to remove the medium. Immediately thereafter, 4% paraformaldehyde in PBS was added, followed by 20 min of incubation at room temperature. Then, the paraformaldehyde was aspirated, PBS was added for 10 min, and the cells were permeabilized with 0.2% Triton X-100 and PBS for 10 min at room temperature. Following a brief wash with PBS, the samples were blocked with 3% bovine serum albumin and PBS at room temperature for 15 min, and primary antibodies (rabbit anti-APS or goat anti-CAP) were added in the blocking buffer for 1 h at room temperature. After the incubation with primary antibodies, the cells were washed three times over a 5-min period with PBS at room temperature, and secondary antibodies (rabbit anti-APS Alexa-Fluor 488 donkey anti-rabbit IgG (green) and/or goat anti-CAP Alexa-Fluor 594 donkey anti-goat IgG 2 mg/ml (red)) were added in blocking buffer for 1 h at room temperature. After the secondary antibody incubation, the cells were washed three times over a 5-min period with PBS at room temperature, mounted into glass slides using 50% glycerol, and processed for viewing using an inverted Zeiss Axiophot microscope attached to a laser illumination unit.
Assays for Glucose Uptake and GLUT4 Translocation-The insulinstimulated uptake of glucose was measured by the uptake of 2-deoxy-
3 H]glucose as described (17) . Statistical analysis was performed using Student's t test. Plasma membrane lawns for the analysis of GLUT4 translocation were prepared as described (17) and probed using goat polyclonal GLUT4 antibody (Santa Cruz Biotechnology) and AlexaFluor 594 donkey anti-goat IgG prior to visualization by immunofluorescence microscopy.
Yeast Two-hybrid Analysis-For yeast two-hybrid analysis, we used the LexA system as described previously (6) . IR was expressed as a fusion to LexA. The mouse CAP cDNA was subcloned into the vector GADT7 (Clontech).
Transient Transfection and Immunoprecipitations-Wild type and mutant APS constructs were transiently transfected using FuGENE 6, and proteins were immunoprecipitated with the 9E10 anti-Myc antibody coupled to agarose in the case of APS or the anti-FLAG antibody coupled to agarose.
Gene Silencing of the Mouse APS Gene-Gene silencing was performed using the pSuperRetro plasmid purchased from Oligoengine, Seattle, WA. In brief, a duplex oligonucleotide corresponding to the mouse APS gene was subcloned into pSuperRetro that had been digested with BglII and HindIII. As a control, a scrambled duplex oligonucleotide, in which the corresponding sequence (5Ј-ACGTCGTAGCA-CACTACG-3Ј) replaced those of APS, was synthesized and subcloned as described above. The recombinant plasmids were transfected into Phoenix packaging cells using FuGENE 6, and 48 h after transfection the cell culture medium was filtered with a 0.2 m filter and used to infect 3T3-L1 fibroblasts after the addition of 4 mg/ml polybrene. Infected cells were selected with puromycin (10 mg/ml), and clones were isolated by limiting dilution and then differentiated and screened for the expression of APS. Transient knockdowns using synthetic siRNA for human c-Cbl and Cbl-b (Smartpool siRNA, Dharmacon, Inc) at a concentration of 100 nM were performed as described (18) in a cultured human adipocyte cell line (19) . The sequences for the siRNA used are as follows: c-Cbl (5Ј-GGAGACACATTTCGGATTA; 5Ј-GATCTGACCTGC-AATGATT-3Ј; 5Ј-GACAATCCCTCACAATAAA-3Ј; 5Ј-CCAGAAAGCTT-TGGTCATT-3Ј); and Cbl-b (5Ј-GACCATACCTCATAACAAG-3Ј; 5Ј-TG-AAAGACCTCCACCAATC-3Ј; 5Ј-GATGAAGGCTCCAGGTGTT-3Ј; 5Ј-TATCAGCATTTACGACTTA-3Ј).
Peptide Synthesis-The biotinylated APS phosphopeptide was synthesized by the Biopolymer Unit at the University of Nottingham Medical School by John Keyte and purified and characterized by mass spectrometry.
RESULTS

Analysis of the Interaction between CAP and the Insulin
Receptor-Since CAP has been reported to interact with the insulin receptor, we wanted to determine the molecular basis for this interaction and define the domains that interacted by using the yeast two-hybrid system as described previously. We expressed the insulin receptor as a fusion with the LexA DNA binding domain, and CAP was fused to the GAL4 activation domain and tested in parallel with APS ( Fig. 1) . As has been observed previously (6, 7) , a robust interaction between the insulin receptor and APS was seen. We tested the interaction of CAP and different mutants of the insulin receptor, including a kinase-dead mutant, because CAP is thought to bind constitutively to the insulin receptor in the absence of activation. We could not detect binding of CAP to phosphorylated kinaseactive, kinase-inactive, or phosphorylation-defective mutants of the insulin receptor. The expression and correct nuclear FIG. 1. CAP does not interact with the insulin receptor. The wild type insulin receptor (IR) and various kinase-dead and phosphorylation-defective mutants were fused to the LexA DNA binding domain (BD), CAP was fused to the GAL4 DNA activation domain (AD), and interactions were analyzed using a standard yeast two-hybrid ␤-galactosidase filter assay. Blue indicates a positive interaction. KD, ATPbinding site kinase-dead insulin receptor; YE3, insulin receptor containing tyrosine to glutamate substitutions at the activation loop phosphorylation sites 1158, 1162 and 1163; 1158F, 1162F, and 1163F, tyrosine to phenylalanine substitutions of the respective residues; and YF2, tyrosine to phenylalanine substitutions of amino acids 1338 and 1334.
localization of these proteins was verified previously by using immunoblotting as described (6) .
Interaction of CAP with the C Terminus of APS-Next, we transiently transfected wild type APS and mutant forms of APS into CHO.T cells that expressed FLAG-tagged CAP. The cells, which were unstimulated, were lysed, and CAP was precipitated with anti-FLAG. The immunoprecipitates were immunoblotted with antibodies to insulin and anti-Myc. Fig. 2 shows that Myc-tagged APS is readily detected in the immunoprecipitates, but we could not detect the insulin receptor in the immunoprecipitates despite the high levels of co-expression and the use of high affinity antibodies to the insulin receptor. Deletion of residues 534 -621 (M1) in the C terminus of APS abolished the interaction with CAP, suggesting that a prolinerich region in the C terminus of the insulin receptor interacts with the SH3 domain of CAP.
Only APS, but Not CAP, Facilitates c-Cbl Phosphorylation-Next, we analyzed c-Cbl phosphorylation in these cells (Fig. 3) . We used an APS-derived phosphopeptide containing tyrosine 618 to precipitate c-Cbl from these cells, and this phosphopeptide was then analyzed for tyrosine phosphorylation using antiphosphotyrosine antibodies. The unphosphorylated APS peptide was used as a control. We found that this reagent was much more efficient at precipitating c-Cbl than the antibodies that we used in the past (3). The figure shows that co-expression of the insulin receptor and CAP did not reconstitute insulin-stimulated c-Cbl phosphorylation, but the co-expression of APS resulted in robust insulin-stimulated c-Cbl phosphorylation.
Because this result and previously published results suggested that the recruitment of APS facilitated the movement of c-Cbl to the receptor, we next determined whether the knockdown of the APS gene in 3T3-L1 adipocytes would result in the loss of insulin-stimulated c-Cbl phosphorylation (Fig. 4) . We tested the hypothesis that APS is necessary for c-Cbl phosphorylation in 3T3-L1 adipocytes with siRNA-mediated gene silencing delivered by stably suppressing the expression of mouse APS in 3T3-L1 adipocytes with a retroviral system (20) . Using a retroviral system to generate siRNA against the APS protein resulted in an 80% decrease in the expression of APS. This was sufficient to abolish c-Cbl phosphorylation without affecting the expression of CAP or c-Cbl. As can be seen from Fig. 4 , the reduction of APS expression, while leaving the expression of CAP intact, abolished insulin-stimulated phosphorylation of c-Cbl in 3T3-L1 adipocytes. Concomitantly with the abolition of insulin-stimulated Cbl phosphorylation, there was a marked reduction (70%) in insulin-stimulated glucose uptake and GLUT4 translocation as assessed by the plasma membrane sheet assay. In a separate experiment, c-Cbl and Cbl-b were silenced using synthetic siRNA. This resulted in an ϳ50% inhibition of insulin-stimulated glucose transport (Fig. 4d) . However, in both instances, even though it was reduced, insulin-stimulated glucose uptake was still detectable.
Redistribution of CAP in Response to Insulin Occurs Only When APS Is Co-expressed-We analyzed the subcellular localization of CAP by immunofluorescence (Fig. 5 ) or subcellular fractionation (Fig. 6 ) before and after insulin stimulation. In CHO.T CAP cells, insulin did not alter the localization of CAP, but the co-expression of APS with CAP facilitated the movement of CAP to the cytosol. In the basal state (Fig. 5) , CAP was localized to the membrane when APS was co-expressed. Upon insulin stimulation, there was a redistribution of CAP to the cytosol. In contrast, in cells that only expressed CAP and insulin receptor, there was no change with insulin.
Similar results were obtained by crude subcellular fractionation (Fig. 6) . The cells were lysed and then separated into detergent-soluble and insoluble fractions (membrane and pellet) by centrifugation. Insulin or phorbol esters triggered the loss of CAP from the pellet fraction in CHO.T-APS-CAP cells but not in CHO.T-CAP cells.
Insulin Stimulates the Dissociation of APS and CAP-We next analyzed the effects of insulin stimulation on the association of APS and CAP (Fig. 7A) . In the basal state, APS is constitutively associated with CAP as detected by immunoprecipitation, but, following insulin stimulation, there is a marked decrease in the amount of CAP bound to APS, suggesting that these proteins dissociate as a result of insulin stimulation.
Interaction of SH2-B with CAP and Insulin-stimulated Dissociation-Because SH2-B is similar to APS and has broadly similar functions, we assessed the role of SH2-B using coexpression of SH2-B and CAP (Fig. 7B) . Under basal conditions, SH2-B is also constitutively bound to CAP. The addition of insulin decreased the amount of SH2-B bound to CAP as detected using anti-Myc immunoblotting, indicating that the interaction of SH2-B and CAP is regulated in a manner similar to that of APS.
DISCUSSION
Over the last few years, it has emerged that there are two pathways necessary for insulin-stimulated GLUT4 translocation, namely an insulin receptor substrate/PI 3-kinase-dependent pathway and a PI 3-kinase-independent pathway that requires the APS adapter protein, CAP, and c-Cbl (2). Insulin stimulates the phosphorylation of c-Cbl and b-Cbl in differentiated 3T3-L1 adipocytes, but not in undifferentiated fibroblasts or CHO.T cells expressing high levels of insulin receptor, indicating that an adipocyte-specific accessory protein is required for this to occur (21) . Two such adipocyte-specific proteins were identified previously. First, CAP was identified as a c-Cbl-binding protein in a yeast two-hybrid screen of an adipocyte-library by using Cbl as bait and it was proposed to be the protein that recruits c-Cbl (10). However, we and others sub- sequently found that APS coupled the insulin receptor to Cbl in a ligand-dependent manner (3, 4) . Thus, both APS and CAP appeared to facilitate the recruitment of c-Cbl to the insulin receptor via distinct mechanisms. APS is also expressed specifically in adipocytes and appears to provide the mechanism for the ligand-dependent recruitment of c-Cbl.
We embarked on this study to understand the molecular basis of the interaction of CAP with the insulin receptor and to determine the relative roles of the two proteins, APS and CAP, in recruiting c-Cbl. This was achieved by using a relatively simple strategy. First, we attempted to delineate interactions in the yeast two-hybrid system. Using both kinase-active and kinase-defective mutants, no interaction of CAP with the insulin receptor could be detected.
The absence of these proteins in CHO cells allows a fortuitous opportunity to dissect the events involved. APS and CAP were ectopically expressed in CHO.T cells that do not express these proteins. As has been described previously (4), CAP was constitutively bound to APS under basal conditions, but we could not detect any interaction between the insulin receptor and CAP under conditions of overexpression and detection with high affinity antibodies. Interestingly, we found that deletion of the C terminus of APS abolished the interaction of CAP with APS, indicating that the C terminus contains the important interacting motifs.
CAP interacts with c-Cbl through an SH3 domain-mediated interaction through the C-terminal SH3 domain (10) . However, CAP can also interact with APS through the C-terminal SH3 domain (4) . In contrast, the interaction of APS and c-Cbl is phosphorylation-dependent and occurs following the binding of the variant SH2 domain of c-Cbl to the phosphorylated Tyr-618 of APS (4). CAP is thought to be constitutively bound to the insulin receptor and dissociates from the receptor following insulin stimulation (10, 11) .
We used these cells to analyze the phosphorylation of c-Cbl. We had shown previously that the ectopic expression of APS to CHO.T cells expressing the insulin receptor was sufficient to reconstitute the insulin-stimulated phosphorylation of c-Cbl (3). We wanted to determine whether similar results could be obtained if CAP was co-expressed with the insulin receptor in the absence and presence of APS. Consistent with the data obtained previously by us and others (3, 4), we could not reconstitute or increase the phosphorylation of c-Cbl by simple overexpression of CAP, but we could easily detect it if APS was co-expressed, with or without CAP. The next strategy we used was to determine whether the silencing of the mouse APS gene would be sufficient to abolish insulin-stimulated c-Cbl phosphorylation in 3T3-L1 adipocytes. Expression of the mouse APS gene was reduced by 80% using siRNA, and this resulted in the loss of insulin-stimulated c-Cbl phosphorylation and a reduction in insulin-stimulated glucose uptake and GLUT4 translocation, indicating that the APS protein was essential for this FIG. 5 . Insulin stimulates the redistribution of CAP only in the presence of APS. CHO.T-CAP cells and CHO.T-APS-CAP cells were serum-starved and then stimulated with insulin. The cells were then fixed, and CAP or APS were visualized by staining with anti-FLAG antibody and anti-Myc 9E10, respectively, followed by secondary antibody as described (red for FLAG and green for Myc). The antibodies were then visualized by confocal microscopy. event. However, even though it was impaired, insulin-stimulated glucose uptake was still detectable.
In the basal state, there is a significant amount of APS localized to the plasma membrane. In addition CAP appears to be localized to the membrane and, following insulin stimulation, adopts a diffuse cytoplasmic distribution. This relocalization from the plasma membrane only occurs when APS is co-expressed.
Interestingly, insulin stimulation resulted in the dissociation of CAP from APS after several minutes. However, a previous study (4) did not find evidence for an insulin-stimulated dissociation. The reason for that finding is not obvious, but it may be a result of time course differences. The interaction of APS with CAP appears to be mediated by the C terminus of APS, because deletion of the C terminus abolished the interaction of APS with CAP. The dissociation of APS from CAP may explain why an apparent dissociation of CAP from the insulin receptor may be observed following insulin stimulation (10) . APS binds with high affinity to the insulin receptor and probably remains bound for some time after CAP and c-Cbl have translocated to a distinct compartment away from the receptor to initiate the events leading to GLUT4 translocation.
The C-terminal SH3 domain of CAP has been shown to bind to APS. To determine which part of APS interacted with CAP, deletions were engineered in APS, and the mutants were transfected into CHO.T CAP cells. We found that removal of the C terminus of APS abolished the interaction of APS with CAP. Examination of the sequence of APS revealed four proline-rich regions in APS, of which three are contained in the C terminus. Because the C-terminal SH3 domain is utilized by both APS and CAP, it is not likely that CAP bridges a ternary complex, and, in fact, such a scenario is probably unnecessary, because the mechanisms for the recruitment of CAP and Cbl appear to be distinct. Thus, it is likely that APS directs the formation of this ternary complex to the insulin receptor. This idea is supported by the immunofluorescence results showing that CAP will translocate in cells only when APS is co-expressed, suggesting that APS is required to direct the movement of CAP between different compartments, at least in the initial proximal signaling events. Interestingly, a CAP mutant deficient in the lipid raft association inhibits the phosphorylation of c-Cbl, presumably by mistargeting c-Cbl or APS (4) . There is also a pool of CAP proteins that would be constitutively bound to c-Cbl and would be recruited indirectly by being transported by c-Cbl when c-Cbl binds to phosphorylated APS. The importance of this second pool is not clear and will have to be addressed using mutants of APS that are defective in recruiting c-Cbl. It is possible that these two mechanisms, in combination, provide a means for amplifying the amount of CAP that is localized to the membrane.
While this manuscript was under review, Minami et al. (22) reported the phenotype of the APS knock-out mice. These mice display increased insulin sensitivity and hypoinsulinemia, which is unexpected and is the reverse of the predicted phenotype. It is possible that in these mice SH2-B␣ provides an alternative mechanism for the recruitment of CAP, because it binds to CAP constitutively and dissociates upon insulin stimulation. We have shown previously that SH2-B has broadly similar functions to APS in insulin signaling (8, 15 ). Here we show, for the first time, that SH2-B interacts with CAP, and this would explain the absence of a loss-of-function phenotype. It should be noted that, although glucose uptake was impaired, it was not abolished in the cells used in the present study, suggesting that other proteins may play a role in compensating for insulin-stimulated glucose transport when APS is decreased or absent.
Why do these mice display a gain-of-function phenotype? One possibility is that the deletion of APS abrogates a negatively regulatory function that is either contained in APS itself or requires APS for initiation. One such candidate is c-Cbl. We and others have shown previously that phosphorylation of APS facilitates the recruitment of Cbl (3, 4) . SH2-B is a weaker substrate for the insulin receptor (15) and, hence, is less able to facilitate the recruitment of c-Cbl, a known negative regulator of tyrosine kinases. The loss of Cbl recruitment could potentially explain the gain-of-function. Another possibility is that APS recruits other proteins that play a negative role in insulin signaling and that the deletion of APS abolishes the negative effects of these proteins. We have recently identified one such candidate recruited by APS and specifically expressed in adipocytes. 2 There may be other compensatory mechanisms that occur in the context of a knock-out mouse that are not seen in a cultured cell system, such as 3T3-L1 adipocytes, and these mechanisms may explain the differences seen both in this study and in other studies (4, 9, 22) .
Taken together, the data from these studies indicate the following sequence of events (summarized Fig. 8 ). First, APS is recruited to the insulin receptor following insulin stimulation. This allows it to transport CAP to the insulin receptor. The localization of CAP to the membrane is aided by its constitutive interaction with APS, even though there may be a pool of CAP proteins carried by c-Cbl. Phosphorylation of APS then allows it to recruit Cbl. Thus, APS provides a central mechanism for the recruitment of both CAP and Cbl and is therefore both necessary and sufficient for the ligand and phosphorylation-dependent recruitment of c-Cbl. The data also indicate that APS is important for the recruitment of Cbl. After the initial recruitment, CAP dissociates from APS and presumably re-associates with Cbl, allowing transportation to the lipid rafts that are enriched in flotillin.
